Related Experiment Video
Updated: Oct 23, 2025

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Trauma-induced pulmonary thromboembolism: What's update?
1Emergency and Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vascular Disease, Beijing, 100029, China.
Severe trauma patients face high risks of pulmonary thromboembolism and bleeding. This review addresses key questions regarding safe anticoagulant therapy, including risk factors, timing, and management strategies for venous thromboembolism.
Area of Science:
- Trauma and Critical Care Medicine
- Hematology
- Pharmacology
Background:
- Trauma-induced pulmonary thromboembolism is a leading cause of mortality in severe trauma.
- Patients exhibit complex coagulation issues, including fibrinolytic hyperactivity and hypercoagulability.
- Managing anticoagulation in trauma presents significant clinical challenges.
Purpose of the Study:
- To review and answer critical clinical questions regarding venous thromboembolism in severe trauma.
- To guide safe and effective anticoagulant therapy in this patient population.
- To address risk factors, diagnostic challenges, and therapeutic strategies for traumatic venous thromboembolism.
Main Methods:
- Literature review of clinical studies and guidelines.
- Synthesis of current evidence on trauma-induced coagulation dysfunction.
- Analysis of risk factors, prophylaxis, and management of anticoagulation-related hemorrhage.
Main Results:
- Identifies key risk factors for traumatic venous thromboembolism.
- Discusses methods for assessing coagulation status in trauma patients.
- Outlines optimal timing and agent selection for pharmacologic prophylaxis.
- Provides strategies for managing anticoagulation-related hemorrhage and restarting chemoprophylaxis.
Conclusions:
- Safe and effective anticoagulant therapy in severe trauma requires addressing specific clinical questions.
- A comprehensive understanding of risk factors and coagulation status is crucial.
- Optimal timing and agent selection for prophylaxis and management of complications are essential for improving patient outcomes.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:

